aibio
Listings ·
Neutra Corp. files Form 15 to end SEC reporting duties
The notice, dated December 11, 2024, lists 16 holders of record of its common stock.
NTRR Neutra Corp.
Neutra (NTRR) news
Latest Neutra news
We have not published a story on Neutra yet. When there is news, it will appear here.
Neutra annual financials
Questions about Neutra
What is the ticker symbol of Neutra?
Neutra Corp. trades under the ticker NTRR on OTC.
Where is Neutra listed?
Neutra Corp. is listed on OTC.
What is the SEC CIK of Neutra?
The SEC Central Index Key (CIK) for Neutra Corp. is 1512886. Its filings are on SEC EDGAR.
How many shares does Neutra have outstanding?
2,917,899,124 shares as of 2023-12-15, per the cover page of its 10-Q filed 2023-12-15.
Which country or territory is Neutra listed under?
Our directory records Neutra Corp. under United States.
What does Neutra do?
Our directory classifies Neutra Corp. as: Biotechnology. This is a directory classification, not a description of the pipeline.
What is the ISIN of Neutra?
The ISIN recorded for Neutra Corp. is US64129C3034.
Does aibio.space cover Neutra?
aibio.space lists Neutra Corp. among 2,820 public biotech companies and publishes its news here as stories appear.
Where is Neutra incorporated?
SEC records list its state or country of incorporation as WY.
What was Neutra's revenue last year?
$67,996 for the fiscal year ended Jan 31, 2023, as reported to the SEC.
Is Neutra profitable?
Neutra Corp. reported a net loss of $561,417 for the fiscal year ended Jan 31, 2023, and used $153,243 of cash in operations, per its annual report to the SEC.
How much cash does Neutra have?
$692 in cash at Oct 31, 2023, per its 10-Q.
What is the latest Neutra (NTRR) stock news?
Our latest story on Neutra, dated Dec 12, 2024: "Neutra Corp. files Form 15 to end SEC reporting duties". The notice, dated December 11, 2024, lists 16 holders of record of its common stock. Source.
Is Neutra at risk of delisting?
Our latest listing story, dated Dec 12, 2024: "Neutra Corp. files Form 15 to end SEC reporting duties". The notice, dated December 11, 2024, lists 16 holders of record of its common stock. Source.
Is Neutra a smaller reporting company?
SEC records list Neutra Corp.'s filer category as: Non-accelerated filer<br>Smaller reporting company.
Investor discussion: Neutra
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Capital-markets timeline
- Listings
Filed to end its SEC reporting. SEC Form 15-12G. Source
Stock chart
SEC filings and registration
- SEC name
- Neutra Corp.
- CIK
- 1512886
- Industry (SIC)
- Medicinal Chemicals & Botanical Products (2833)
- US tickers
- NTRR (OTC)
- State or country of incorporation
- WY
- Fiscal year ends
- January 31
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- Business address
- 2500 CITYWEST BLVD., HOUSTON, TX, 77042
- Phone
- (307) 228-1488
- Shares outstanding
- 2,917,899,124 as of 2023-12-15 (10-Q filed 2023-12-15)
Recent filings
Listing details
- Company
- Neutra Corp.
- Ticker
- NTRR
- Listing
- OTC
- Country or territory
- United States
- Business scope
- Biotechnology
- ISIN
- US64129C3034
- Last quote in directory
- 2026-10-21
- Directory source
- Listing page
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction